Resources

Strengthening Ligence’s Export Potential

Ligence Heart receives FDA 510(k) clearance

AI successfully automates heart chamber quantification during stress echocardiography

Ligence study published in Echocardiography (Wiley)

Ligence Heart validated in study from John Paul II Hospital in Krakow

Validating AI for fully automated LV mass measurement in echocardiography

Ensuring the path to correct AS diagnosis – is AI an adequate and promising tool?

AI matches expert accuracy in assessing LV diastolic dysfunction

AI outperforms experts in LV mass assessment: new JACC study

Ligence ‘Takes Over’ ESC’s Journal

Four abstracts co-authored by our team have been published, marking a historic milestone: for the first time, AI has surpassed human performance in echocardiographic analysis. However, this is not about

Historic Milestone in Echocardiography: AI Surpasses Humans

Ligence Attracts €3 Million Investment

Ligence, a leader in echocardiography automation technology, has attracted €3 million in seed funding led by venture capital firm Simpact Ventures. This funding will drive Ligence’s expansion efforts as the